{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:22:18Z","timestamp":1740108138298,"version":"3.37.3"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T00:00:00Z","timestamp":1510099200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["NN 407 012 036"],"award-info":[{"award-number":["NN 407 012 036"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Microbiol Immunol"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s00430-017-0526-x","type":"journal-article","created":{"date-parts":[[2017,11,7]],"date-time":"2017-11-07T23:33:35Z","timestamp":1510097615000},"page":"55-63","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Higher expression of inhibitory CD158b and CD158e NK cell receptor and age predicts treatment response in children with chronic hepatitis C"],"prefix":"10.1007","volume":"207","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0141-2560","authenticated-orcid":false,"given":"Anna","family":"Mania","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariusz","family":"Kaczmarek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawe\u0142","family":"Kemnitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Mazur-Melewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Figlerowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Sikora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech","family":"S\u0142u\u017cewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"\u017beromski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,8]]},"reference":[{"key":"526_CR1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/hep.27259","volume":"61","author":"JP Messina","year":"2015","unstructured":"Messina JP, Humphreys I, Flaxman A et al (2015) Global distribution and prevalence of hepatitis C virus genotypes. Hepatology 61:77\u201387","journal-title":"Hepatology"},{"key":"526_CR2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1159\/000341680","volume":"30","author":"S Lunemann","year":"2012","unstructured":"Lunemann S, Schlaphoff V, Cornberg M, Wedemeyer H (2012) NK cells in hepatitis C: role in disease susceptibility and therapy. Dig Dis 30:148\u201354. \n                        https:\/\/doi.org\/10.1159\/000341680","journal-title":"Dig Dis"},{"doi-asserted-by":"crossref","unstructured":"Mondelli MU, Varchetta S, Oliviero B (2010) Natural killer cells in viral hepatitis: facts and controversies. Eur J Clin Investig 40;851\u2013863","key":"526_CR3","DOI":"10.1111\/j.1365-2362.2010.02332.x"},{"key":"526_CR4","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/hep.24556","volume":"54","author":"L Golden-Mason","year":"2011","unstructured":"Golden-Mason L, Bambha KM, Cheng L et al (2011) NK inhibitory receptor expression associated with treatment failure and Il-28B genotype in patients with chronic hepatitis C. Hepatology 54:1559\u20131569","journal-title":"Hepatology"},{"issue":"9","key":"526_CR5","doi-asserted-by":"publisher","first-page":"e99426","DOI":"10.1371\/journal.pone.0099426","volume":"13","author":"JR Vidal-Casti\u00f1eira","year":"2014","unstructured":"Vidal-Casti\u00f1eira JR, L\u00f3pez-V\u00e1zquez A, Mart\u00ednez-Borra J et al (2014) Diversity of killer cell immunoglobulin-like receptor (KIR) genotypes and KIR2DL2\/3 variants in HCV treatment outcome. PloS One 13(9):e99426. \n                        https:\/\/doi.org\/10.1371\/journal.pone.0099426","journal-title":"PloS One"},{"key":"526_CR6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.19.1.197","volume":"19","author":"A Moretta","year":"2001","unstructured":"Moretta A, Bottino C, Vitale M et al (2001) Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 19:197\u2013223","journal-title":"Annu Rev Immunol"},{"key":"526_CR7","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S1074-7613(00)80394-5","volume":"7","author":"M Uhrberg","year":"1997","unstructured":"Uhrberg M, Valiante NM, Shum BP et al (1997) Human diversity in killer cell inhibitory receptor genes. Immunity 7:753\u2013763","journal-title":"Immunity"},{"key":"526_CR8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jhep.2013.03.003","volume":"59","author":"B Oliviero","year":"2013","unstructured":"Oliviero B, Mele D, Degasperi E et al (2013) Natural killer cell dynamic profile is associated with treatment outcome in patients with chronic HCV infection. J Hepatol 59:38\u201344","journal-title":"J Hepatol"},{"key":"526_CR9","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1016\/j.molimm.2008.01.002","volume":"45","author":"V Romero","year":"2008","unstructured":"Romero V, Azocar J, Zuniga J, Et (2008) al. Interaction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in hepatitis C virus infection outcome. Mol Immunol 45:2429\u20132436","journal-title":"Mol Immunol"},{"key":"526_CR10","first-page":"1094","volume":"61","author":"A Ascione","year":"2014","unstructured":"Ascione A, Bruno S, Coppola C et al (2014) Treatment outcomes and predictors of response in treatment-naive HCV patients treated with peginterferon alfa\/ribavirin in real-world ormali clinics: sub-analysis from the PROPHESYS Cohort. Hepatogastroenterology 61:1094\u2013106","journal-title":"Hepatogastroenterology"},{"key":"526_CR11","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s00705-015-2364-8","volume":"160","author":"Q Ling","year":"2015","unstructured":"Ling Q, Chen J, Zhou H et al (2015) Baseline factors associated with treatment response in patients infected with hepatitis C virus 1b by stratification of IL28B polymorphisms. Arch Virol 160:1105\u20131112. \n                        https:\/\/doi.org\/10.1007\/s00705-015-2364-8\n                        \n                     (Epub 2015 Feb 18)","journal-title":"Arch Virol"},{"key":"526_CR12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/hep.1840200104","volume":"20","author":"Anonymous","year":"1994","unstructured":"Anonymous (1994) Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology 20:15\u201320","journal-title":"Hepatology"},{"key":"526_CR13","first-page":"518","volume":"38","author":"CT Wai","year":"2003","unstructured":"Wai CT, Greenson JK, Fontata RJ et al (2003) A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38:518\u2013526","journal-title":"Hepatology"},{"key":"526_CR14","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jhep.2010.01.016","volume":"52","author":"S Wirth","year":"2010","unstructured":"Wirth S, Ribes-Koninckx C, Calzado MA et al (2010) High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin. J Hepatol 52:501\u2013507","journal-title":"J Hepatol"},{"key":"526_CR15","first-page":"319","volume":"69","author":"W S\u0142u\u017cewski","year":"2012","unstructured":"S\u0142u\u017cewski W, Kowala-Piaskowska A, Wysocki J et al (2012) Treatment of chronic hepatitis C in children with pegylated interferon \u03b12a and ribavirin\u2014a multi-center study. Acta Pol Pharm 69:319\u2013326","journal-title":"Acta Pol Pharm"},{"key":"526_CR16","first-page":"S263","volume":"68","author":"A Mania","year":"2015","unstructured":"Mania A, Kaczmarek M, Kemnitz P et al (2015) Expression of inhibitory CD158b and CD 158e receptors is associated with significant liver injury in the course of chronic hepatitis C in children. Abstracts of The International Liver Congress\u2122 2015\u201350th Annual meeting of the European Association for the Study of the Liver. J Hepatol 68:S263","journal-title":"J Hepatol"},{"key":"526_CR17","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.humimm.2014.06.003","volume":"75","author":"T Umemura","year":"2014","unstructured":"Umemura T, Ota M, Katsuyama Y et al (2014) KIR3DL1-HLA-Bw4 combination and IL28B polymorphism predict response to PEG\u2013IFN and ribavirin with and without telaprevir in chronic hepatitis C. Hum Immunol 75:822\u2013826. \n                        https:\/\/doi.org\/10.1016\/j.humimm.2014.06.003\n                        \n                     (Epub 2014 Jun 11)","journal-title":"Hum Immunol"},{"key":"526_CR18","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1002\/hep.25771","volume":"56","author":"L Golden-Mason","year":"2012","unstructured":"Golden-Mason L, Stone AE, Bambha KM, Cheng L, Rosen HR (2012) Race- and gender-related variation in natural killer p46 expression associated with differential anti-hepatitis C virus immunity. Hepatology 56:1214\u20131222. \n                        https:\/\/doi.org\/10.1002\/hep.25771","journal-title":"Hepatology"},{"key":"526_CR19","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1002\/hep.23477","volume":"51","author":"S Knapp","year":"2010","unstructured":"Knapp S, Warshow U, Hegazy D et al (2010) Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus. Hepatology 51:1168\u20131175. \n                        https:\/\/doi.org\/10.1002\/hep.23477","journal-title":"Hepatology"},{"key":"526_CR20","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1128\/JVI.01285-09","volume":"84","author":"JR Vidal-Casti\u00f1eira","year":"2010","unstructured":"Vidal-Casti\u00f1eira JR, L\u00f3pez-V\u00e1zquez A, D\u00edaz-Pe\u00f1a R et al (2010) Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection. J Virol 84:475\u2013481. \n                        https:\/\/doi.org\/10.1128\/JVI.01285-09","journal-title":"J Virol"},{"key":"526_CR21","doi-asserted-by":"publisher","first-page":"e1001184","DOI":"10.1371\/journal.ppat.1001184","volume":"6","author":"D Sene","year":"2010","unstructured":"Sene D, Levasseur F, Abel M et al (2010) Hepatitis C virus (HCV) evades NKG2D-dependent NK cell responses through NS5A-mediated imbalance of inflammatory cytokines. PloS Pathog 6:e1001184. \n                        https:\/\/doi.org\/10.1371\/journal.ppat.1001184\n                        \n                     (Epub 2010\/11\/19)","journal-title":"PloS Pathog"},{"key":"526_CR22","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.clim.2015.03.008","volume":"158","author":"L Golden-Mason","year":"2015","unstructured":"Golden-Mason L, Waasdorp Hurtado CE, Cheng L, Rosen HR (2015) Hepatitis C viral infection is associated with activated cytolytic natural killer cells expressing high levels of T cell immunoglobulin- and mucin-domain-containing molecule-3. Clin Immunol 158:114\u2013125","journal-title":"Clin Immunol"},{"key":"526_CR23","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/hepr.12322","volume":"45","author":"I Nakamura","year":"2015","unstructured":"Nakamura I, Asano T, Asabe S et al (2015) Restoration of natural killer cell activity by pegylated interferon-alpha\/ribavirin therapy in chronic hepatitis C patient. Hepatol Res 45:107\u2013112. \n                        https:\/\/doi.org\/10.1111\/hepr.12322","journal-title":"Hepatol Res"},{"key":"526_CR24","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1053\/j.gastro.2011.06.069","volume":"141","author":"G Ahlenstiel","year":"2011","unstructured":"Ahlenstiel G, Edlich B, Hogdal LJ et al (2011) Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C. Gastroenterology 141:1231\u20131239. \n                        https:\/\/doi.org\/10.1053\/j.gastro.2011.06.069","journal-title":"Gastroenterology"},{"key":"526_CR25","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1053\/j.gastro.2015.03.004","volume":"149","author":"E Serti","year":"2015","unstructured":"Serti E, Chepa-Lotrea X, Kim YJ et al (2015) Successful interferon-free therapy of chronic hepatitis C virus infection ormalizes natural killer cell function. Gastroenterology 149:190\u2013200","journal-title":"Gastroenterology"},{"key":"526_CR26","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/infdis\/jiv391","volume":"213","author":"M Spaan","year":"2016","unstructured":"Spaan M, van Oord G, Kreefft K et al (2016) Immunological analysis during interferon-free therapy for chronic hepatitis C virus infection reveals modulation of the natural killer cell compartment. J Infect Dis 213:216\u2013223","journal-title":"J Infect Dis"}],"container-title":["Medical Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00430-017-0526-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-017-0526-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-017-0526-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,23]],"date-time":"2018-01-23T01:56:38Z","timestamp":1516672598000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00430-017-0526-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,8]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["526"],"URL":"https:\/\/doi.org\/10.1007\/s00430-017-0526-x","relation":{},"ISSN":["0300-8584","1432-1831"],"issn-type":[{"type":"print","value":"0300-8584"},{"type":"electronic","value":"1432-1831"}],"subject":[],"published":{"date-parts":[[2017,11,8]]}}}